Inhibition of Allergen-Induced Histamine Release from Human Basophils by Cyclosporine A and FK-506

International Archives of Allergy and Immunology

Volumn 114, Issue 1, 1997, Pages 68-73

  Sperr, Wolfgang R ^a   Valenta, R ^b   Semper, H ^a   Liehl, E ^d   Susani, M ^c   Willheim, M ^b   Scheiner, O ^b   Lechner, K ^a   Valent, P ^a  

^a Division of Hematology and Hemostaseology   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c Institute of Molecular Biology Salzburg   (Austria)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Basophils; Histamine release; Recombinant allergens

Indexed keywords

CYCLOSPORIN A; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENT; POLLEN ANTIGEN; TACROLIMUS;

ARTICLE; BASOPHIL; CLINICAL ARTICLE; GRASS POLLEN; HISTAMINE RELEASE; HUMAN; HUMAN CELL; POLLEN ALLERGY; PRIORITY JOURNAL;

EID: 8544235030     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237645     Document Type: Article

References (40)

1. Ishizaka K, Ishizaka T: Mechanisms of reaginic hypersensitivity and IgE antibody response, Immunol Rev 1978;41:109-148.
2. Froese A: Receptors for IgE on mast cells and basophils, Prog Allergy 1984;34:142-187.
3. Valenta R, Sperr WR, Ferreira F, Valent P, Sil-labcr Ch, Trcjkl M, Duchene M, Kraft D, Scheiner O: Induction of specific histamine release from basophils with purified natural and recombinant birch pollen allergens, J Allergy Clin Immunol 1992;91:88-97.
4. Vrtala S, Sperr WR, Reimitzer I, van Rce R, Laffer S, Muller WD, Valent P, Lechner K, Rumpold H, Kraft D, Scheiner O, Valenta R: cDNA cloning for a major allergen from timothy grass (Phleum pralense) pollen; characterization of the recombinant Plil p V allergen, JImmunol 1993;151:4773-4781.
5. Ferreira FD, Mayer P, Sperr WR, Valent P, Sei-berler S, Ebner Ch, Liehl E, Scheiner O, Kraft D, Valenta R: Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2, J Allergy Clin Immunol I996;97:95-103.
6. Borel JF, Feurer C, Gubler HU, Staehlin H: Biologic effects of cyclosporin-A: A new antilym-phocytic agent, Agents Actions I976;6:468-475.
7. Calnc RY, Thiru S, MacMaster P, Craddock GN, White DJG, Evans DB, Dunn DC, Pentlow BD, Rollos K: Cyclosporin A in patients receiving renal allograft from cadaver donors, Lancet 1978;2: 1323-1332.
8. Tindall RSA, Rollins JA, Phillips JT, Greenlee RG, Wells L, Belcndiuk G: Preliminary results of a double blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis, N Engl J Med 1987;316:719-724.
9. Stiller CR, Dupre J, Gent M, Jenner MR, Ke-own PA, Laupacis A, Martell R, Rodger NW, von Graffenried BV, Wolfe BMJ: Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset, Sience 1984;223:1362-1365.
10. Schreiber SL, Crabtree GR: The mechanism of action of cyclosporin A and FK-506, Immunol Today 1992;13:136-142.
11. Kino T, Hatanaka H, Hasimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H: FK-506, a novel immunosuppressant isolated from a Streptomyces, I, Fermentation, isolation, and physico-chemical and biological characteristics, J Antibiot (Tokyo) 1987; 60:1256-1265.
12. de Paulis A, Cirillo R, Ciccarelli A, Condorelli M, Marone G: FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human FceRL cells, J Immunol 1991:146: 2374-2381.
13. Cirillo R, Triggiani M, Siri L, Ciccarelli A, Petit GR, Condorelli M, Marone G: Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cy-clophylin, J Immunol 1990;144:3891-3897.
14. de Paulis A, Cirillo R, Ciccarelli A, deCrescen-zo G, Oriente A, Marone G: Characterization of the anti-inflammatory effect of FK-506 on human mast cells, J Immunol 1991:147:4278-4285.
15. Stcllato C, dc Paulis A, Ciccarelli A, Cirillo R, Patella V, Casolaro V, Marone G: Anti-inflammatory effects of cyclosporin A on human skin mast cells, J Invest Dermatol 1992;98:800-804.
16. Triggani M, Cirillo R, Lichtenstein LM, Marone G: Inhibition of histamine and prostaglandin D; release from human lung mast cells by cyclosporin A, Int Arch Appl Immunol 1989; 88:235-255.
17. Speir WR, Agis H, Czerwenka K, Virgolini I, Bankl HC, Muller MR, Zsebo K, Lechner K, Valent P: Effects of cyclosporine-A (CSA) FK-506 on stem cell factor (SCF)-induced histamine secretion and growth of human mast cells, J Allergy Clin Immunol 1996;98:389-399.
18. Valcnta R, Duchcnc M, Vrtala S, Birkner T, Ebner C, Hirschwehr R, Breitenbach M, Rum-pold H, Scheincr O, Kraft D: Recombinant allergens for immunoblot diagnosis of tree pollen allergy, J Allergy Clin Immunol 1991;88:889-894.
19. Valenta R, Vrtala S, Ebner C, Kraft D, Scheiner O: Diagnosis of grass pollen allergy with recombinant timothy grass (Phlenm pratense) pollen allergens, Int Arch Appl Immunol 1992; 97:287-294.
20. Breiteneder H, Pettcnburgcr K, Bito A, Valcnta R, Kraft D, Rumpold H, Scheiner O, Brciten-bach M: The gene coding for the major birch pollen allergen Belvl, is highly homologous to a pea disease resistance response gene, EMBO J 1989;8:1935-1938.
21. Valenta R, Duchene M, Pettenburger K, Sillaber C, Valent P, Bcttclhcim P, Brcitcnbach M, Rum-pold H, Kraft D, Scheiner O: Identification of Profilin as a novel pollen allergen: IgE autoreactivity in sensitized individuals, Science 1991;88:889-894.
22. Affcr S, Valenta R, Vrtala S, Susani M, van Ree R, Kraft D, Scheiner O, Duchene M: Complementary DNA cloning for the major allergen Phi p 1 from timothy grass (Pltleum pratense): Recombinant Phi p/inhibits IgE binding to group I allergens from eight different grass species, J Allergy Clin Immunol 1994;94:689-698.
23. Dolecek C, Vrtala S, Laffer S, Steinbcrgcr P, Kraft D, Scheincr O, Valente R: Molecular characterization of Phi p II, a major grass (Pltleum pratense) pollen allergen, FEBS Lett 1993;335:299-304.
24. Menz G, Dolecek C, Schonhcit-Kcnn U, Ferreira F, Moser M, Scheider T, Suter M, Boltz-Nitu-lescu G, Ebner C, Kraft D, Valenta R: Serological and skin-test diagnosis of birch pollen allergy with recombinant Bet v I, the major birch pollen allergen, Clin Exp Allergy I996;26:50-60.
25. Vrtala S, Susani M, Sperr WR, Valent P, Laffer S, Dolecek C, Kraft D, Valenta R: Immunologic characterization of purified recombinant timothy grass pollen (Pltleum pratense) allergens (Phi p 1, Phi p2, Phi p 5), J Allergy Clin Immunol 1996;97:781-787.
26. Valcnta R, Duchcnc M, Valent P, Sillaber C, Deviller P, Ferreira F, Tejkl M, Edelmann H, Kraft D, Scheiner O: Profilins constitute a novel family of functional plant pan allergens, J Exp Med 1992;175:377-385.
27. Susani M, Jcrtschin P, Dolecek C, Sperr WR, Valent P, Ebner C, Kraft D, Valenta R, Scheiner O: High level expression ofbirch pollen profilin (Bet v 2) in Escherichia coli: Purification and characterization of the recombinant allergen, Biochcm Biophys Res Commun 1995;215: 250-263.
28. Ferreira FD, Hoffman-Sommergruber K, Breiteneder H, Pettenburger K, Ebner C, Sommer-grubcr W, Steiner R, Bohle B, Sperr WR, Valent P, Kungl AJ, Breitenbach M, Kraft D, Scheiner O: Purification and characterization of recombinant Bet v /, the major birch pollen allergen, J Biol Chcm 1993;28:19574-19580.
29. Valent P, Besmer J, Muhm M, Maijdic O, Lechner K, Bettelheim P: Interleukin 3 activates human blood basophils via high-affinity binding sites, Proc Natl Acad Sei USA 1989:86: 5542-5547.
30. Willheim M, Agis H, Sperr WR, Koller M, Bankl HC, Kiener H, Fritsch G, Füreder W, Spittler A, Graninger W, Scheiner O, Gadner H, Lechner K, Boltz-Nitulescu G, Valent P: Purification of human basophils and mast cells by multistep separation technique and mAb to Cdwl7 and CD 117/c-kit, J Immunol Methods 1995;182:115-129.
31. Alexander AG, Barnes NC, Kay AB: Trial of cyclosporin in corticosteroid-dependent chronic severe asthma, Lancet 1992;339:324-328.
32. Shevach F.M: The effects of cyclosporin A on the immune system, Annu Rev Immunol 1985; 3:397-423.
33. Sawada S, Suzuki C, Kawase Y, Takaku F: Novel immunosuppressive agent, FK-506: In vitro effects on cloned T cell activation, J Immunol 1987;139:1797-1803.
34. Kaufmann Y, Rosenberg SA: Blocking by cyclosporine of antigen-induced maturation and lymphokine secretion by cytotoxic T lymphocyte hybridomas, Transplantation 1984;38: 148-154.
35. Krönke M, Leonard WL, Depper JM, Arya SK, Wong-Staal F, Gallo RC, Waldmann TA, Green WC: Cyclosporin A inhibits T cell growth factor gene expression at the level of mRNA transcription, Proc Natl Acad Sei USA 1984:81:5214-5218.
36. Hess AD, Donnenberg AD, Tuschka PJ, Santos GW V: Effect of cyclosporin A on human lymphocyte responses in vitro: Analysis of responding T lymphocyte subpopulation in primary MLR with monoclonal antibodies, J Immunol 1983;130:717-724.
37. Handschumachcr RE, Harding MW, Rice J, Drugge RJ, Speicher DW: Cyclophilin: A specific cytosolic binding protein for cyclosporine A, Science 1984;226:544-547.
38. Takahishi N, Hayano T, Suzuki M: Peptidyl-prolyl-cis-trans isomcrasc is the cyclosporinc-A-birding protein cyclophilin, Nature 1989; 337:473-475.
39. Fischer G, Wittman-Liebold B, Lang K, Kief-haberT, Schmid FX: Cyclophilin and peptidyl-prolyl-cis-trans isomerase are probably identical proteins, Nature 1989;337:476-478.
40. Harding MW, Galat A, Uehling DE, Schreiber SL: A receptor for the immunosuppressant FK-506 is a cis-trans peptidyl prolyl isomerase, Nature 1989;341:758-760.